Skip to main content
Homepage
AGING Analysis Report
Sep 4, 2026
18 days ago · 100% complete
For AI assistants & researchers — machine-readable summary of this page

What this page is: Delvantic's full research page for Carpenter Technology Corporation (CRS) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.

Our current read (analysis of 2026-09-22): Designation Low · Gem Score -21 (−100…+100 Quality+Value blend) · Quality 71 · Value -83 · Sentiment 34 (timing only, not weighted) · Composite fair value $73.21 vs $467.48 at analysis

Page map (sections in order; each card carries a stable reference-name attribute you can cite):

  • profile-header / price-overview — company profile, live quote, market cap
  • extended-analysisthe core: three AI lens reads with findings, scores, and the analyst memo
  • future-predictions — our forward price-band predictions
  • market-narrative / ai-findings / gpt-critique — narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)
  • Members-only sections (render as login gates for anonymous readers): price-history, income-trend, key-metrics, financials (statement tables), insider-trading. The analysis above is public; the raw data tables require a free account.

More for machine readers: site briefing at /llms.txt · any ticker resolves at delvantic.com/stock/TICKER · raw inputs are public-company filings and market data (via licensed data feeds); every model, score, lens read, and prediction on this page is Delvantic's own analysis.

Carpenter Technology Corporation

CRS NYSE
Industrials · Metal Fabrication
Philadelphia, PA 19103, United States carpentertechnology.com Updated Sep 4, 12:00am
Price
$467.48
Market Cap
$23.2B
Employees
4,500
Beta
1.28
Avg Volume
791,923
Last Dividend
$0.80
CEO
Mr. Tony R. Thene CPA

Carpenter Technology Corporation is a specialty metals manufacturer that produces and distributes high-performance alloys and engineered metal products. The company serves critical end markets including aerospace, defense, medical, energy, transportation, industrial, and consumer electronics. Its product portfolio includes titanium alloys, stainless steels, alloy steels, tool steels, powder metals, and metal powders used in demanding applications that require strength, precision, and reliability. Carpenter Technology operates through two main business segments, Specialty Alloys Operations and Performance Engineered Products, supporting customers with materials used in components, parts, and advanced manufacturing processes. Headquartered in Philadelphia, Pennsylvania, the company is a significant supplier in the specialty materials market, where it plays a key role in providing advanced metal solutions for performance-driven industries.

Runs with full report Generated: Sep 4, 2026 12:13am
Price Overview
Price at report time
$467.48
as of Sep 4, 12:00am (18d ago)
Change · Sep 4
+6.51 (+1.41%)
Day Range
$458.13 – $476.39
52-Week Range
$228.00 – $625.99
50-Day MA
$548.59
200-Day MA
$431.57
Volume
490,600.00
Right now · live
Log in to get the live feed
Members see the real-time price and the move since this report (over 18d).
Share Structure
Outstanding 49,558,566.00
Float 48,392,949.00
Free Float 97.6%
High free float — 97.6% of shares trade freely, ~2.4% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Sep 4, 2026 12:56am (18d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Sep 4, 2026 12:13am (18d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
TD Twelve Data statement HEX SEC filing
Industry comparison last run: Sep 4, 2026 12:11am
P/E · trailing (TTM) (Price per dollar of earnings over the past year — not a run-rate or forward P/E)
HEX
Stock Price / EPS (Diluted)
44.44
Stock Price: $467.48
EPS (Diluted): 10.52
P/B Ratio (Price vs net asset value)
HEX
Stock Price / Book Value Per Share
10.58
Stock Price: $467.48
Total Equity: $2.23B
Shares: 50,400,000
EV/EBITDA (Total value vs operating profit)
HEX
Enterprise Value / EBITDA
27.88
Market Cap: $23.17B
Total Debt: $690.70M
Cash: $393.30M
EBITDA: $849.10M
Enterprise Value (Takeover price (cap + debt - cash))
HEX
Market Cap + Total Debt - Cash
$23.7B
Market Cap: $23.17B
Total Debt: $690.70M
Cash: $393.30M
Gross Margin (Revenue left after direct costs)
HEX
Gross Profit / Revenue
30.6%
Gross Profit: $955.50M
Revenue: $3.12B
Operating Margin (Revenue left after all operations)
HEX
Operating Income / Revenue
22.5%
Operating Income: $702.00M
Revenue: $3.12B
Net Margin (Revenue left as actual profit)
HEX
Net Income / Revenue
17.0%
Net Income: $529.80M
Revenue: $3.12B
ROE (Profit from shareholder equity)
HEX
Net Income / Total Equity
23.8%
Net Income: $529.80M
Total Equity: $2.23B
ROIC (Profit from all invested capital)
HEX
NOPAT / Invested Capital
22.4%
Operating Income: $702.00M
Tax Rate: 19.3%
Equity: $2.23B
Total Debt: $690.70M
Cash: $393.30M
Current Ratio (Can it pay short-term bills)
HEX
Current Assets / Current Liabilities
3.81
Current Assets: $1.98B
Current Liabilities: $520.00M
Debt/Equity (Leverage — debt vs equity)
HEX
Total Debt / Total Equity
0.31
Short-Term Debt: $0.00
Long-Term Debt: $690.70M
Total Debt: $690.70M
Total Equity: $2.23B
Rev/Share (Top-line per share)
HEX
Revenue / Shares Outstanding
$61.99
Revenue: $3.12B
Shares: 50,400,000
Book Value/Share (Net assets per share)
HEX
(Total Assets - Total Liabilities) / Shares
$44.20
Total Equity: $2.23B
Shares: 50,400,000
FCF/Share (Real cash generated per share)
HEX
(Operating Cash Flow + CapEx) / Shares
$7.19
Operating CF: $605.00M
CapEx: -$242.70M
Shares: 50,400,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
TD
Last Annual Dividend / Stock Price
0.2%
Last Dividend: $0.80
Stock Price: $467.48
Payout Ratio (Earnings paid out as dividends)
HEX
Dividends Paid / Net Income
7.6%
Dividends Paid: -$40.30M
Net Income: $529.80M
Industry Benchmarks
Last run: Sep 4, 2026 12:11am
Compares CRS against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Income Statement (Annual)
Last updated: Sep 4, 2026 12:13am (18d ago)
Metric 2022 2023 2024 2025 2026
Revenue $1.8B $2.6B $2.8B $2.9B $3.1B
Cost of Revenue $1.7B $2.2B $2.2B $2.1B $2.2B
Gross Profit $149.8M $337.3M $584.3M $768.6M $955.5M
Operating Expenses $174.7M $204.2M $261.2M $246.8M $253.5M
Operating Income -$24.9M $133.1M $323.1M $521.8M $702.0M
Net Income -$49.1M $56.4M $186.5M $376.0M $529.8M
EBITDA $106.5M $264.1M $457.7M $661.0M $849.1M
EPS $-1.01 $1.15 $3.75 $7.50 $10.59
EPS (Diluted) $-1.01 $1.14 $3.70 $7.42 $10.52
Balance Sheet (Annual)
Last updated: Sep 4, 2026 12:00am (18d ago)
Metric 2022 2023 2024 2025 2026
Cash & Equivalents $154.2M $44.5M $199.1M $315.5M $393.3M
Total Current Assets $1.1B $1.3B $1.6B $1.8B $2.0B
Total Assets $2.9B $3.1B $3.3B $3.5B $3.8B
Current Liabilities $375.6M $459.4M $466.3M $483.7M $520.0M
Long-Term Debt $691.8M $693.0M $694.2M $695.4M $690.7M
Total Liabilities $1.6B $1.7B $1.7B $1.6B $1.6B
Total Equity $1.3B $1.4B $1.6B $1.9B $2.2B
Retained Earnings $1.2B $1.2B $1.4B $1.7B $2.2B
Cash Flow (Annual)
Last updated: Sep 4, 2026 12:56am (18d ago)
Metric 2022 2023 2024 2025 2026
Operating Cash Flow $6.0M $14.7M $274.9M $440.4M $605.0M
Capital Expenditure -$91.3M -$82.3M -$96.6M -$154.3M -$242.7M
Free Cash Flow -$85.3M -$67.6M $178.3M $286.1M $362.3M
Acquisitions (net)
Net Debt Issued / (Repaid) -$300.0M $0 $0 $0 -$700.0M
Dividends Paid -$39.2M -$39.4M -$40.0M -$40.3M -$40.3M
Stock Buybacks $0 $0 -$101.9M -$179.1M
Net Change in Cash -$133.2M -$109.7M $154.6M $116.4M $77.8M
Growth Trends (YoY %)
Last updated: Sep 4, 2026 12:13am (18d ago)
Metric 2023 2024 2025 2026
Revenue Growth +38.9% +8.2% +4.3% +8.6%
Gross Profit Growth +125.2% +73.2% +31.5% +24.3%
Operating Income Growth +634.5% +142.7% +61.5% +34.5%
Net Income Growth +214.9% +230.7% +101.6% +40.9%
EBITDA Growth +148.0% +73.3% +44.4% +28.5%
Dividend History (Last 20)
Last updated: Aug 31, 2026 11:31am (22d ago)
Date Dividend Declaration Record Payment
2026-08-25 $0.20
2026-04-28 $0.20
2026-01-27 $0.20
2025-10-21 $0.20
2025-08-26 $0.20
2025-04-22 $0.20
2025-01-28 $0.20
2024-10-22 $0.20
2024-08-27 $0.20
2024-04-22 $0.20
2024-01-29 $0.20
2023-10-23 $0.20
2023-08-21 $0.20
2023-05-01 $0.20
2023-01-30 $0.20
2022-10-24 $0.20
2022-08-22 $0.20
2022-05-02 $0.20
2022-01-31 $0.20
2021-10-25 $0.20
0Company Classification 1Industry Landscape 2Company Momentum 3Forward Projection 4aDCF Valuation 4bEarnings Power Value 4cAnchored PE 4dReverse DCF 4eRevenue-Based DCF 4fAnchored P/S 4gScenario Analysis 4hDividend Discount Model 4iBook Value Analysis 4jInsider Activity 4fCash Flow Quality 4gDebt Maturity Risk 4hMacro Environment 4iSector Intelligence 4jRevenue Confidence 4kSensitivity Analysis 4lSector Demand Cycle 5AI Investigation 5bThesis Evaluation 6Valuation Synthesis
computed not applicable 18 computed · 6 not applicable
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-09-22 02:02
-0.8 : 1 +1σ upside vs −1σ downside, from this company's own quarterly history
A +1σ run of quarters pays -68%; a −1σ run costs 82%. Ratio -0.8:1 (μ 9.0%, σ 9.1% , 16 pairs).
CaseGrowthMarginFair valuevs price ($467.48)
Bull — recovery +13% 19.5% $130.81 -72%
Base — stabilizes +8% 17.0% $101.73 -78%
Bear — keeps slipping +4% 14.4% $77.74 -83%
Upside — a +1σ run of quarters (v2) +18% 18.7% $147.32 -68%
Stress — a −1σ run of quarters (v2) -0% 18.7% $84.30 -82%
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for CRS — it's generated by the pipeline (market-narrative step).
Growth Outlook
Analyzed 2026-09-04 01:07

The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.

Growing Capacity-constrained specialty alloy franchise compounding revenue at high single digits with earnings growing ~5x faster on price/mix — durable direction, but the earnings-slope math decays and cannot approach what the price assumes. conf 7/10
Share gain Category growing · Revenue growth of 8.59% sits exactly on the category median 8.59% — the company is holding volume share while capturing a disproportionate share of category PROFIT, with earnings +41% against a category growing high single digits.
Next 2 quarters
Growing
Mills remain loaded, contract repricing continues to flow through, and the last four prints show a stable pattern of modest operating outperformance. Sequential EPS progression (2.33 to 2.77 to 3.23) is intact with no evident order-book crack.
↑ above expectations
Year 1
Growing
Full-year trajectory is supported by contracted volume and already-agreed pricing; the delta year-on-year is mostly locked. Earnings growth should stay well above revenue growth but begin to narrow as the easiest reprice comparisons lap.
≈ inline with expectations
Years 2–3
Growing
Earnings power should still be higher in three years — engine spares demand, defense funding and qualification moats persist, and expansion capital adds incremental tonnage. But the growth RATE decays toward high-single-digit revenue and low-to-mid-teens earnings as repricing exhausts and the cycle matures.
↓ below expectations
The creme: each rung's call measured against what's already printed (vs analyst estimates · vs guidance / FY consensus · vs price-implied growth) — expectations in print are already in the price, so only the variant margin can pay. Hover a rung's chip for the margin read.
Growth drivers
75 Aerospace engine ramp with qualified-supplier lock-in — Engine OEM build rates and spares demand are rising into a multi-year commercial ramp; Carpenter's alloys are qualification-locked into specific rotating-part specs, so demand cannot be resourced quickly. This is volume visibility, not order-book hope, and it underwrites at least several more quarters of full mill loading.
74 Sold-out capacity converted into price/mix, not tonnage — Revenue +8.6% YoY while earnings +41% YoY is the signature of a constrained asset allocating hours to the highest-value alloys and repricing multi-year agreements. This mechanism is why earnings CAGR (68%) dwarfs revenue CAGR (6.4%) and it still has runway as older contracts roll.
43 Category in confirmed expansion — Metal fabrication category median recent growth 8.59% and 7.7% 3-yr industry CAGR with an expansion-phase demand read — the tide is with the business, so growth does not depend on taking volume from rivals.
37 Defense and medical mix ballast — Defense alloy demand is budget-backed and medical (implantables, titanium) grows on demographics rather than the industrial cycle, damping the historical amplitude of specialty-metals cyclicality.
27 Consistent execution above plan — Four of the last five prints beat EPS estimates by ~5-12%, a repeatable operating pattern that suggests internal productivity and pricing capture are running slightly ahead of the models.
Growth risks
68 Capacity ceiling caps revenue growth — With mills effectively full, top-line growth is bounded by price and mix until brownfield expansion lands. That mathematically converts today's 40% earnings growth into mid-teens then high-single-digit growth as reprice-benefit laps itself.
68 Price-implied growth is unmeetable — The reverse-DCF requires ~60% growth vs a plausible high-single-digit revenue / mid-teens earnings path. Nothing in the capacity or category math supports that rung, so the structural horizon is the weakest link.
47 Aerospace destocking / OEM rate slip — Airframer and engine rate resets propagate up the alloy chain with a lag; a single rate cut plus supply-chain inventory correction can turn a sold-out mill into a volume air pocket, as the -211% EPS print of Nov-2025 showed the model has tail events.
32 Late-cycle specialty metals risk — The category is in expansion phase now, but expansion phases are where specialty metals peak; macro headwinds with 10y at 4.79 pressure industrial, transportation and energy end markets first.
The world is re-arming and re-fleeting at the same time: commercial aviation is working through a decade-long delivery backlog while defense budgets across NATO and Asia step up, and both consume the same narrow set of qualified high-temperature and titanium alloys. Qualification barriers mean supply cannot flex to meet that demand for years, so value accrues to the few incumbent mills. Against this, higher-for-longer rates (10y 4.79) and industrial macro headwinds pressure the transportation, energy and consumer-electronics slices of the portfolio — a mix drag, not a thesis break. The structural read is that Carpenter's business direction is upward and supply-advantaged, while the cyclical read warns this is the good part of the cycle, not the start of one.
Growth position composite +11
ShrinkingStallingHoldingGrowingAccelerating
70Next 2 quarters · Growing
70Year 1 · Growing
70Years 2–3 · Growing
+11Composite (−100…+100)
A research prediction, not advice. Forward-graded: each rung is scored against the prints that follow it. Not an input to the GEM designation — track record first.
Claude Reading
Independent analyst synthesis · claude-opus-4-7 · generated 2026-09-04 00:55:38
Verdict Overvalued but the synthesis's $81 fair value is wrong — real fair value is $275-325 on peak-margin normalization; avoid at $467, revisit below $325 or after Q1 FY27 confirms margin durability.

Looking at the raw numbers first: CRS has executed a genuine transformation. FY22 operating income was -$25M on $1.84B revenue; FY26 it's $702M on $3.12B. Gross margin went from 8.1% to 30.6%; net margin from -2.7% to 17.0%. The quarterly cadence is not decelerating — Q4 FY26 hit $851M revenue and 19.1% net margin, the best print in the series, up from $717M/11.8% eight quarters prior. ROIC of 22.5% and FCF of $362M ($7.30/share) are real. This is not a fake beat; the operating leverage is throwing off cash and the balance sheet is clean ($690M debt vs $393M cash, 3.8x current ratio).

That said, the valuation math the synthesis presents is directionally right but the $81 fair value is comically low and undermines the case. At $467, market cap $23.2B, TTM earnings ~$530M puts the P/E at 43.7x, EV/EBITDA ~28x, EV/Sales ~7.6x. For a specialty metals manufacturer — even a best-in-class one — that's aerospace-multiple territory (HEI, TDG) applied to a business with capex intensity ($243M capex vs $605M OCF, i.e., 40% reinvestment) and cyclical end markets. A defensible fair value on a mature-earner framework using 20-25x forward earnings on ~$600M NI is $12-15B, or $240-300/share. That's a 35-50% overvaluation, not 82%. The synthesis DCF is anchored on normalized/mid-cycle assumptions that ignore the current earnings power entirely.

Where I'd push back on the bear consensus: the "mix normalizes" thesis has been the bear call since margins were 12%, and margins have continued climbing to 19%. Carpenter's SAO segment genuinely benefits from a structural qualification moat in aerospace alloys — requalifying a supplier for turbine disks takes years. Boeing 737/787 rate ramps and F-35 sustainment are multi-year committed backlogs, not order-book vapor. The bull case for durability at these margins isn't insane; it's the magnitude of the premium that's insane. The August 25 cluster of insider sales — 10 sales same day, ~50K shares — is not a smoking gun (likely 10b5-1 or option-exercise related given uniform date) but it's certainly not confidence-signaling near $467 either. A contrarian would note: nobody is buying.

The models contradict themselves in a useful way. Rule-based says mature_earner; pre-flight says cyclical industrial with margin transformation; narrative engine calls it a fragile bubble at 82% premium; thesis evaluator scores -10 (nearly balanced). The honest read is between these: it's a high-quality cyclical caught at peak margins with a legitimate structural story, priced as if the peak is permanent. Revenue CAGR of 6.4% doesn't support the multiple; earnings CAGR of 68.6% does, but off a near-zero base — mean reversion in that growth rate is mechanical, not a bear thesis. If margins hold at 17% and revenue grows 8%, FY28 EPS is roughly $13-14; at a generous 25x that's $325-350. To justify $467 you need either margin expansion to continue (20%+ net) or a re-rating to 30x+ mature-industrial multiples that has no historical precedent absent a bubble.

I agree with the synthesis direction (overvalued) but strongly dissent on the magnitude. Fair value is $275-325, not $81. The $81 print makes the analysis dismissible to anyone who's watched the operational execution. At $467, the stock is pricing in aerospace supercycle continuation through 2028+ with no margin give-back — a bet, not an investment. I would not short (quality is real, momentum is intact, no earnings deceleration visible) but I would not initiate long here. Wait for either a $325 handle on a cyclical scare or a Q1 FY27 print that confirms 20%+ net margins are sticky.

GPT Reading
Independent reading · gpt-5.4 · generated 2026-09-04 00:55:57
Verdict Overvalued at $467 — this is a genuinely improved franchise, but the market is capitalizing peak-to-near-peak margins as if they are permanently compounding; fair value looks closer to $275-$325.

The numbers show a real operating transformation, not a mirage. Carpenter has gone from a loss in FY2022 on $1.84B of revenue to $529.8M of net income on $3.12B in FY2026, with operating income up from negative $24.9M to $702.0M. That is not just end-market recovery; it is a profound margin reset. Gross margin expanded from 8.1% in FY2022 to 30.6% in FY2026, operating margin to 22.5%, and net margin to 17.0%. The quarterly progression is even more striking: net margin moved from 11.8% in Sep-2024 to 19.1% in Jun-2026 while revenue climbed from $717.6M to $851.0M. Over the last four quarters, revenue ran about $3.12B annualized and net income about $529.8M, but the exit rate is higher still: the last two quarters alone produced $302.0M of net income on $1.66B of revenue, an 18.2% net margin. Cash generation supports the quality of earnings. FY2026 operating cash flow was $605.0M versus $529.8M of net income, and even after heavy $242.7M capex, free cash flow was $362.3M. The balance sheet is not what you see in a strained late-cycle steel name either: $393.3M cash, $690.7M debt, current ratio 3.81, debt/equity 0.31.

What stands out to me is that the market is paying not for today's earnings, but for the belief that this new earnings power keeps compounding from here. At $23.17B market cap, the stock trades at 7.5x sales, 44.4x trailing earnings, 27.9x EV/EBITDA, and 10.6x book. Those are software-like multiples on a specialty metals producer. Even if I reject the absurdity of the model-derived $70-$80 fair values, the core objection remains: a company growing revenue 8.6% YoY and likely benefitting from unusually strong aerospace/defense mix should not need to be valued on heroic assumptions. On FY2026 free cash flow, the stock is around a 1.6% FCF yield. To justify that, you need either sustained 20%+ earnings growth for years or confidence that margins still have room to move materially higher from already exceptional levels. The raw data does not prove that. Revenue growth has been good, but not explosive: $2.76B to $2.88B to $3.12B over the last three years. The earnings surge has come far more from margin than volume. That is exactly the part of the story I am least willing to underwrite at 44x earnings.

The strongest pushback is that this is not a commodity steel rerating but a scarcity-value franchise in high-spec alloys, and the numbers do support a structural quality argument. ROIC of 22.5% and ROE of 23.8% are elite for an industrial manufacturer. Quarterly revenue did not just recover; it re-accelerated from $728.0M in Dec-2025 to $811.5M and then $851.0M, while margins also rose, which suggests pricing power and mix are still improving rather than rolling over. If the business has moved into a new regime where aerospace engines, defense systems, and additive/powder metallurgy command persistently higher margins, then a simple reversion-to-midcycle framework will badly understate value. A bull can also point to disciplined capital deployment: the company is funding nearly $243M of capex while still producing $362M of free cash flow and carrying manageable net debt of roughly $297M. If FY2027 earnings were to reach, say, $650M-$700M with similar cash conversion, today’s multiple would compress quickly.

I still weigh the bear case more heavily because the valuation already assumes that favorable scenario and then some. This is a $23B equity value on a business that generated $3.12B of sales and $362M of free cash flow last year. Even if I capitalize earnings rather than cash and grant that FY2026 is not the peak, there is no room for a normal industrial wobble. The insider tape does not help: the latest ten reported insider transactions are all sales on the same date, and while that can reflect options or planned dispositions, it is not the signal you want when the stock is priced for perfection. The contradiction I see in the prior outputs is not that the stock is expensive — it clearly is — but that some model outputs overstate the case by pretending a cyclical industrial deserves a low-teens multiple on current earnings. Carpenter deserves a premium because the operating improvement is real. It just does not deserve this premium. I would not anchor fair value at $80; I would anchor it much higher, but still far below $467. A 22x-28x earnings range on $530M-$600M of sustainable earnings implies something more like $235-$335 per share, depending on share count and how much of the current margin profile you treat as structural.

What would change my mind is straightforward: if the next 2-3 quarters show revenue above $850M consistently and net margins holding in the 18%-20% range without a working-capital unwind masking deterioration, then I would accept that FY2026 was not peak-ish but merely an intermediate step. Likewise, if FY2027 free cash flow can move from $362M to well north of $500M after capex, the valuation debate changes because the equity would no longer be trading at a sub-2% cash yield on peak conditions. On the other hand, if quarterly revenue slips back toward $730M-$760M or net margin retraces to the low teens, the stock should de-rate hard because too much of the current price is attached to permanence of unusually high profitability.

Grok Reading
Independent reading · grok-4.5 · generated 2026-09-04 00:56:32
Verdict Operationally excellent specialty-metals franchise trading at ~44× earnings and ~1.6% FCF yield; fair value closer to $200–250 than $467

The raw numbers describe a genuine industrial transformation, not a statistical fluke. Carpenter went from a $49M loss and negative operating income in FY2022 to $530M of net income on $3.12B of revenue in FY2026, with gross margin expanding from high-single digits to 30.6% and operating margin landing at 22.5%. The latest quarter is the strongest yet: $851M revenue and a 19.1% net margin, up from $756M and 14.8% a year earlier. Free cash flow of $362M against only $691M of debt and a 3.8 current ratio means the balance sheet is clean and the earnings are cash-backed. ROIC at 22.5% and ROE at 24% confirm that the mix shift into aerospace and medical alloys is earning an economic return, not just a temporary price spike. That part of the story is real.

What the same numbers refuse to support is the $23B equity value. Revenue has compounded at only 6.4% over the multi-year recovery; the 68% earnings CAGR is almost entirely margin catch-up from a depressed base. At 44× trailing earnings, 7.5× sales and 28× EV/EBITDA, the market is capitalizing today’s peak margins as if they are the new floor and still layering on multi-year volume growth that the top line has not yet delivered. FCF yield is roughly 1.6%—a bond-like return for a cyclical metals fabricator. Even granting the aerospace qualification moat and another 25–30% earnings advance, a 22–25× multiple on forward net income still points closer to the mid-$200s than to $467. The valuation synthesis fair value near $81 is mechanically harsh, but the direction is unambiguous: price has outrun the cash-flow reality by a wide margin. Clustered insider sales on a single August day add a second, independent caution signal.

The strongest counter-argument is that specialty-alloy capacity and OEM qualifications are genuinely scarce, commercial-aerospace build rates still have years of catch-up, and defense budgets are politically sticky. If powder-metallurgy and additive products scale from a small base while gross margins hold above 28–30%, the earnings power could reach $700–800M within a couple of years and the franchise might deserve a mid-20s multiple rather than a classic industrial 15×. Under that math the stock is expensive rather than absurd, and the pullback from $626 already reflects some skepticism. I weigh this less heavily because the bulk of the margin expansion is already in the rear-view mirror, revenue growth remains mid-single-digit, and 44× leaves almost no room for any normalization in mix or pricing—the exact risk the bear case flags.

I would reverse the overvalued call if the next two quarters show revenue accelerating through the mid-teens while gross margin stays at or above 30%, or if management guides FY2027 net income toward $700M+ with visible powder/AM contribution. A sustained drop in aerospace OEM schedules or a gross-margin print back below 26% would confirm the downside case even more forcefully.

Big-3 Panel — where each AI stands
Each AI above independently stated a direction (undervalued, fairly valued, or overvalued) and how strongly it believes it (conviction, 0–5). We combine those into a Bull-Bear Index on a 0–10 scale: 5 is neutral, 10 is maximum bullish (undervalued at full conviction), 0 is maximum bearish. We compute the score ourselves with the same arithmetic for every seat — the models never grade their own bullishness — so the three are directly comparable. Δ shows how far each seat sits from the panel average of 1.3; a large Δ marks the dissenting voice, usually the one worth reading.
Claude claude-opus-4-7 2.0
overvalued · conviction 3/5 · Δ +0.7 vs panel · self: 3.0
GPT gpt-5.4 1.0
overvalued · conviction 4/5 · Δ -0.3 vs panel · self: 3.0
Grok grok-4.5 1.0
overvalued · conviction 4/5 · Δ -0.3 vs panel · self: 2.0
Advanced Analysis Forensic deep-dive · separate lenses
Separate reads — Company Quality (is it a great business?), Valuation (is it mispriced?), and General Sentiment (how macro + narrative are pushing it), kept deliberately apart · 2026-09-04 01:09:26
Delvantic - Cairn AI
Great business, wrong price - pass, revisit on a break 8/10
CRS is a genuinely transformed specialty-metals franchise trading at a price that requires the aerospace super-cycle to be permanent - pass at $467, wait for a real drawdown.
The cruxWhether the 30% gross margin and $360M+ FCF run-rate are structural (sole-source aerospace positions) or cyclical peak - the entire 3x-6x price gap hinges on this single question.
Forensic checks Derived mechanically from CRS's filed financials — not from the AI lenses
Liquidity & RunwaySelf-Funding
DilutionStable Share Count
Earnings QualityHigh Earnings Quality
The four lensesswitch a tab for its full read — score + evidence
Company Quality
+71
Strong
edge √Σ 139 · risk √Σ 51 · conf 8/10

The trajectory is striking: revenue grew from $1.84B (2022) to $3.12B (2026), gross margin expanded from 8.2% to 30.6%, operating margin from -1.4% to 22.5%, and net income swung from a $49M loss to $530M profit. FCF flipped from -$85M to +$362M over the same window. Earnings quality supports the reported numbers: accruals -1.4% of assets, Beneish M -2.44 (no manipulation flag), and Altman Z of 11.31 puts the balance sheet firmly in the safe zone. Share count is essentially flat (48.5M to 50.4M, ~1% CAGR) with SBC only 0.9% of revenue and buybacks running 2.9x SBC, so per-share value is protected. The business carries net debt of $297M against $362M annual FCF, which is a modest constraint rather than a threat - roughly 0.8x FCF, easily serviceable. OCF/NI of 0.79x is the one soft spot in an otherwise pristine picture, suggesting working capital absorption during growth but not distortion. The CEO's concentrated single-day sale of ~68K shares (~$32M) on 2026-08-25, with zero insider buys over 12 months, is a behavioral yellow flag on an otherwise excellent operational tape.

Strengths 4
m85
Massive margin expansion
Gross margin nearly quadrupled from 8.2% to 30.6% and op margin swung from -1.4% to 22.5% over four years - indicates real pricing power and/or mix shift in specialty alloys, not accounting.
m70
Clean earnings quality
Accruals -1.4% of assets, Beneish M -2.44, Altman Z 11.31. Mechanical checks show no manipulation signals despite the sharp earnings ramp.
m65
FCF inflection with disciplined share count
FCF went from -$85M to +$362M; diluted shares grew only 1% CAGR with buybacks at 292% of SBC, so growth is accruing per share.
m55
Balance sheet safely inside capacity
Net debt $297M vs $362M annual FCF (~0.8x) with $393M liquid cash and Altman Z of 11.31 - constrained but not stressed.
Concerns 3
m40
Concentrated CEO selling
CEO Thene executed 22 sales totaling ~$53M on a single day (2026-08-25) with zero offsetting buys in 12 months - notable behavioral signal even if often programmatic.
m25
OCF trails NI
OCF/NI of 0.79x during rapid growth suggests working capital is absorbing cash; benign in context but worth watching if growth slows and inventories stay high.
m20
Cyclical/end-market dependence unverified
The margin ramp is consistent with aerospace/defense specialty alloy tightness; durability depends on structural vs cyclical drivers not visible in the derived data.
This looks like a genuine specialty-metals up-cycle executed well - the margin expansion from 8% to 30% gross is not something you fake, and the earnings-quality checks back it up. Share count discipline is a real positive; management isn't giving the business away in comp. What keeps me from calling it a fortress is the industry (structurally cyclical), the still-present net debt, and the CEO clearing ~$53M in a single tranche with no offsetting insider conviction on the buy side. Business quality is Strong and improving; I'd want filing-level confirmation that the demand backdrop (likely aerospace) is structural before I would push higher.
Verify before trusting this (6)
  • End-market mix (aerospace/defense vs industrial/medical) and customer concentration to gauge cyclicality of the 30.6% GM
  • Whether CEO's 2026-08-25 sales were 10b5-1 scheduled or discretionary, and remaining insider ownership post-sale
  • Order book/backlog disclosures to test durability of the margin ramp
  • Working capital composition - specifically inventory days - to explain OCF/NI of 0.79x
  • Debt maturity schedule and covenants against the $297M net debt position
  • Pension/OPEB obligations typical for legacy specialty steel producers
Valuation / Mispricing
-83
Overvalued
edge √Σ 20 · risk √Σ 140 · conf 7/10
Price $467 vs composite deserved ~$72-$81 (even generously quality-adjusted ~$150-$180) - the stock trades 3x to 6x above any defensible deserved value. attractive below $160.00

The e2e composite pins fair value at $72.26 with a signal-adjusted $81.13, and both the DCF ($74.55) and EPV floor ($67.68) cluster in the same $68-$75 zone. Price is $467.48 - roughly 6x the deserved value implied by cash-flow and earnings-power methods. Even granting that a Strong quality grade and a genuine margin inflection (gross margin 8% to 30%) deserve a premium multiple on today's earnings power, a 6x gap to EPV cannot be closed by quality alone; it requires the current aerospace super-cycle margin to be treated as permanent and growing. That said, a 6x gap this wide against a specialty-metals name with sole-source aerospace positions raises the possibility the DCF/EPV inputs are stale or under-capturing the earnings run-rate - so I hedge the confidence. Even doubling deserved value to ~$160 to give full credit for the turnaround still leaves the stock ~3x rich. The market is pricing perpetual super-cycle economics; the margin of safety is deeply negative.

Cheap signals 1
m20
Quality and clean earnings deserve premium
Strong quality grade (71) and high earnings-quality (score 2) mean deserved value sits above the raw DCF - but a premium of 2x is defensible, not 6x.
Rich / priced-in 4
m88
Price 6x composite fair value
$467.48 vs composite FV $72.26 and signal-adjusted $81.13 - implied upside of -83%. Both DCF ($74.55) and EPV ($67.68) corroborate the same zone.
m75
EPV floor is a hard anchor
Earnings-power floor of $67.68 says current run-rate earnings alone justify roughly one-seventh of the price; the rest is priced-in growth and cycle persistence.
m70
Priced for permanent super-cycle
To bridge to $467 you must assume 30% gross margins hold indefinitely and defense/aero demand compounds - the bear case correctly flags this as cyclical.
m35
Fair-value gap large enough to suggest model lag, but not close it
A 6x gap raises the chance DCF inputs understate run-rate FCF; even so, sanity-checking with a doubled fair value (~$150) still leaves the stock ~3x rich.
I do not care how good the business is here - at $467 against a $68-$81 fair-value cluster, the price is doing all the work. Even if I generously double deserved value to reflect the turnaround the models may not fully capture, I get to maybe $150-$180, and the stock is still 2.5x-3x that. This is a good company at a price that requires the super-cycle to be permanent. I need it materially lower - sub-$160 - before valuation stops being the dominant risk.
Verify before trusting this (4)
  • Latest quarterly aerospace segment margins and backlog duration - is 30% gross margin sustainable or peak?
  • Management guidance on FY normalized EBITDA / FCF run-rate vs the DCF inputs
  • Order book visibility from Boeing/Airbus/defense primes beyond 2026
  • Whether the DCF used stale (pre-turnaround) margin assumptions - would materially raise deserved value if so
General Sentiment
+34
Tailwind
tail √Σ 98 · head √Σ 63 · conf 6/10

The active story on CRS is a strong aerospace/defense supply-scarcity narrative with medium cult following - Sands Capital just publicly championed the name, and analyst-flavored coverage is framing FY27 free cash flow of $400-430M as a continuation, not a peak. That is a real tailwind for a high-beta (1.28) industrial that has already tripled the tape over three years: momentum begets flows, and peer coverage (ATI getting the same bullish aerospace/defense treatment) reinforces the cohort bid. The risk-on tape (VIX 14, near highs) amplifies this - beta 1.28 catches the updraft cleanly.

Tailwinds 3
m68
Aerospace-scarcity narrative in full force
Strong-intensity story with a credible growth-fund endorsement (Sands Capital) and cohort validation (ATI upgraded outlook). This is the dominant press on the tape right now.
m55
Bullish FY27 cash-flow framing
News flow is guiding readers to $400-430M FCF and 'sustained' growth - analyst tone is reinforcing, not questioning, the premium multiple.
m45
Risk-on tape + high beta
VIX 14, S&P near highs, regime risk-on. Beta 1.28 means CRS catches the updraft harder than an average industrial; momentum is strong_positive.
Headwinds 2
m55
Fragile narrative, post-bubble archetype
The story is tagged fragile durability with a 'post-bubble-cynicism' overlay - one aerospace order miss or defense-budget wobble and the 82% narrative premium becomes the story. Latent skeptic base is real.
m30
Rates/valuation macro drag
10y at 4.79% and market PE 25.8 create a slow bleed on premium-multiple industrials; not acute today but caps upside if the narrative wobbles.
Net pressure leans tailwind. The active aerospace-supply narrative is running hot, sell-side and fund letters are reinforcing it, and the risk-on tape plus a 1.28 beta amplify every up-day. But I flag this as a Tailwind, not Strong Tailwind - the narrative is explicitly labeled fragile and the archetype is post-bubble-cynicism, meaning the skeptic camp is armed and waiting for the first crack. Right now the story is winning; that can change on one order miss.
Verify before trusting this (4)
  • Boeing/Airbus production-rate updates or order pushouts
  • Any sell-side downgrade citing valuation - would crack the fragile narrative
  • VIX break above 18 or sector rotation out of aerospace/defense cohort
  • Peer (ATI, HAYN) guidance revisions - cohort tell
The market-wide tape + this name's exposure to it (beta / sector / narrative durability). Context on the non-fundamental pressure — not a call on the business or the price. processId: detail-general-sentiment
Growth Outlook
+11
Growing
edge √Σ 123 · risk √Σ 112 · conf 7/10

The world is re-arming and re-fleeting at the same time: commercial aviation is working through a decade-long delivery backlog while defense budgets across NATO and Asia step up, and both consume the same narrow set of qualified high-temperature and titanium alloys. Qualification barriers mean supply cannot flex to meet that demand for years, so value accrues to the few incumbent mills. Against this, higher-for-longer rates (10y 4.79) and industrial macro headwinds pressure the transportation, energy and consumer-electronics slices of the portfolio — a mix drag, not a thesis break. The structural read is that Carpenter's business direction is upward and supply-advantaged, while the cyclical read warns this is the good part of the cycle, not the start of one.

Growth drivers 5
m75
Aerospace engine ramp with qualified-supplier lock-in
Engine OEM build rates and spares demand are rising into a multi-year commercial ramp; Carpenter's alloys are qualification-locked into specific rotating-part specs, so demand cannot be resourced quickly. This is volume visibility, not order-book hope, and it underwrites at least several more quarters of full mill loading.
m74
Sold-out capacity converted into price/mix, not tonnage
Revenue +8.6% YoY while earnings +41% YoY is the signature of a constrained asset allocating hours to the highest-value alloys and repricing multi-year agreements. This mechanism is why earnings CAGR (68%) dwarfs revenue CAGR (6.4%) and it still has runway as older contracts roll.
m43
Category in confirmed expansion
Metal fabrication category median recent growth 8.59% and 7.7% 3-yr industry CAGR with an expansion-phase demand read — the tide is with the business, so growth does not depend on taking volume from rivals.
m37
Defense and medical mix ballast
Defense alloy demand is budget-backed and medical (implantables, titanium) grows on demographics rather than the industrial cycle, damping the historical amplitude of specialty-metals cyclicality.
m27
Consistent execution above plan
Four of the last five prints beat EPS estimates by ~5-12%, a repeatable operating pattern that suggests internal productivity and pricing capture are running slightly ahead of the models.
Growth risks 4
m68
Capacity ceiling caps revenue growth
With mills effectively full, top-line growth is bounded by price and mix until brownfield expansion lands. That mathematically converts today's 40% earnings growth into mid-teens then high-single-digit growth as reprice-benefit laps itself.
m68
Price-implied growth is unmeetable
The reverse-DCF requires ~60% growth vs a plausible high-single-digit revenue / mid-teens earnings path. Nothing in the capacity or category math supports that rung, so the structural horizon is the weakest link.
m47
Aerospace destocking / OEM rate slip
Airframer and engine rate resets propagate up the alloy chain with a lag; a single rate cut plus supply-chain inventory correction can turn a sold-out mill into a volume air pocket, as the -211% EPS print of Nov-2025 showed the model has tail events.
m32
Late-cycle specialty metals risk
The category is in expansion phase now, but expansion phases are where specialty metals peak; macro headwinds with 10y at 4.79 pressure industrial, transportation and energy end markets first.
vs expectations: ~6m above · 1y inline · 2-3y below
The forward growth verdict — is the business itself likely to grow (next 2 quarters / year 1 / years 2–3), judged against its category and against printed expectations. The full horizon ladder + creme renders on the Growth Outlook card above. Not a call on the price (Valuation owns that) or the tape (Sentiment owns that).
Please log in to view trade setups
The Augustus trade-setup read is a members feature.
Log in
Lenses kept deliberately separate — Company Quality (price-agnostic), Valuation (price-conditional), General Sentiment (non-fundamental macro/narrative pressure), and Growth Outlook (the forward growth verdict). The scores are not blended. Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Price Prediction
Lower -10.8% v0.6.0 View full prediction →

When we made this prediction on Sep 4, 2026, CRS was $476.29. We expect it to be $425.00 by Mar 2027, and we consider it great value under $160.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Sep 4, 2026.

Price when predicted$476.29
Our estimate for Mar 2027$425.00-10.8%
Great value below$160.00
Price history shown (6 Months)

Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.

Community AI Feedback
No community reviews yet for CRS. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
v1.1.651 · a97c0d4f · 2026-09-22 12:18:51